675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, X1
Amended material disclosure
Appoints Michael J. Grissinger to Board of Directors
Investor Presentation
Shareholder Approval of Sixth Amended 2014 Stock and Incentive Plan
To Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154
Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting
Announces Financial Results for the First Quarter Ended March 31, 2026
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Correspondence
Submission Upload
Registration of Securities under Section 12(g)